The sulphydryl population on erythrocyte membrane is shown to vary as a function of the nutritional status of the cell. When an assay based on reaction with Eliman's reagent and controlled conditions were used the mean values (SEM) for the sulphydryl population on the membranes of normal erythrocytes incubated overnight in the presence and absence of glucose were found to be 3-29 (0.27) and 2 56 (0.25) million sulphydryl functions per cell respectively. Under identical conditions rheumatoid erythrocytes incubated in the presence and absence of glucose were found to have a significantly lower sulphydryl population-1-54 (0.08) and 1-15 (0.08) million respectively.
Plasma sulphydryl group concentrations are known to be low in rheumatoid arthritis and to be raised to some extent during treatment with penicillamine' and gold compounds.2 The sulphydryl group concentration can be subdivided into fast or reactive thiol and slow or comparatively unreactive thiol. It is mainly the fast thiol which is affected during treatment.3 Both gold compounds and penicillamine would be expected to react with the available thiols in vivo. During treatment with these compounds, however, alteration in the plasma thiol concentration tends to be slow and follows signs ofclinical improvement rather than rises in plasma gold or penicillamine concentrations. Thus the change is likely to follow amelioration of disease activity rather than cause it.
The intracellular thiol concentration (mainly glutathione) increases within the first few weeks of treatment in patients who subsequently improve. 4 We have noted that during treatment with sodium aurothiomalate most of the gold present in the red cell is in the membrane rather than the cytosol, particularly in non-smokers,5 6 and that in the in vitro experiments with penicillamine some penicillamine crossed the membrane but much of it was absorbed or reacted causing changes in cellular function.7 8 Likely sites for these therapeutic agents to react on the membrane are the available exofacial thiols, and in this preliminary study we have investigated the question of how such groups are altered in rheumatoid arthritis. This initial study was carried out with patients who were not being treated with disease modifying agents as these drugs may further affect the thiol status of the cell membrane. [5] [6] [7] Materials and methods All reagents used in this study were commercially obtained unless otherwise stated. Whole blood was collected in heparinised anticoagulant tubes from 10 healthy normal volunteers and 10 patients with classical or definite rheumatoid arthritis as defined by the American Rheumatism Association criteria. The latter were not receiving any prescribed second line or cytotoxic drugs.
Samples were centrifuged at 3000 rpm for 10 minutes and the supernatant fluid and the buffy white coat removed by suction. The resulting cells were washed three times in 0-125 M Na2HPO4; 0 15 M NaCl buffer (adjusted to pH 7-4 with concentrated hydrochloric acid). The samples were divided into two roughly equal volumes and stored in buffer and buffer/glucose (5 mM) overnight at 4°C in sealed containers (about 16 hours) to produce glucose depleted and activated cells. After this the cells were washed with their respective media: phosphate/saline, with or without 5 mM glucose. The supernatants were carefully checked for lysis by eye and by spectrophotometry (k= 541 nm). Lysed samples were discarded.
The number of cells in a given volume of pellet were counted, and 0 5 ml was transferred to a sterile container with 8-5 ml of the respective buffers and 1-0 ml of 10-3 M Ellman's solution.
The container was gently mixed and allowed to react for 30 minutes. The suspensions were then centrifuged (3000 rpm for 10 minutes), the supernatant removed, and the visible spectrum (600-350 nm) recorded. Ellman's reagent has some definite advantages for the assessment of thiol status on cell membrane. It cannot pass through the membrane and is specific for the sulphydryl function and, furthermore, requires no preparation procedures using radioactive materials. Thus it is possible to estimate the number of thiols and their activity on the cell in the intact state. At high concentrations or with prolonged incubation lysis can be a major problem, however. This may be controlled in two ways. The concentration of ElIman's reagent in contact with the cells can be kept low (-1 mmol/l). It is then necessary to use a fairly large volume of Ellman's solution to ensure that sufficient amounts are present to saturate the sulphydryl populations. The contact time of these solutions must also be controlled. The reaction of a small thiol containing species with ElIman's reagent in solution (equation 1) is rapid with a t,2of less than five minutes. The reaction of a surface based moiety with a solution phase species can take an order of magnitude longer to react. Lysis can be estimated in the visible spectra by the presence of the haemoglobin band at 541 nm and is usually detectable after about three hours. To prevent interference from this source and from the regeneration of the surface thiols by the cell the shorter time period of 30 minutes was used. The Ellman's reagent solution employed was 10-3 M as this was found to provide the most efficient anion generation over the allowed time period.
The sulphydryl populations on the red cell membrane are a direct reflection of the concentration and status of certain proteins in the membrane (fig 1) . Thus although a rough value of 106 sulphydryl groups per cell is to be expected'61'9 (table 1), the actual value will vary depending on The difference between the activated normal cells and the activated rheumatoid cells was analysed with the Mann-Whitney U test. A significant (p<0 01) difference was found between these two groups. A significant (p<001) difference was also found, by the same method, between depleted normal cells and depleted rheumatoid cells.
The difference between the activated and deactivated normal cells was analysed with the Wilcoxon matched pairs signed rank test, and was found to be significant (p<0-01). When this test was applied to the two rheumatoid populations (depleted and activated) a significant (p<001) difference was also found. The values above are somewhat larger than the number quoted above in table 1, largely because of the differences between the methods of assessment. Radiochemical counting of electrophoretic bands follows extensive separation and does not include minor components. The sulphydryl groups on the proteins are also susceptible to oxidation during preparation and electrophoretic separation. The permeabilities ofN-ethy1maleimide used in sodium dodecyl sulphate gel electrophoresis assays and Eliman's reagent used here will be different, with the latter believed to be more permeant. Table 2 shows the overall distribution of sulphydryl groups throughout the entire red cell membrane. 7 A large percentage (41%) of the thiol functions of the membrane are found in the interior by virtue of contributions by the two transmembrane transport proteins (table 1). Notice that a minor increase in the permeability of the thiol probe molecule will tap some of these deeper seated thiols and would be expected to produce a significant increase in the thiol assay and subsequently alter the percentage distribution of the exofacial sulphydryl population shown in fig 1. Thus the Ellman's assay used here might be expected to provide a more accurate assessment of the total exofacial thiol, and the difference between the methods is as would be expected considering that the definition of the term 'exofacial sulphydryl group' depends on the permeability of the reagent used.
The sulphydryl populations on the erythrocyte membrane are found to increase as a direct consequence of the nutritional status of the cell. In this study two extremes are shown-namely, a fully glucose activated and a fully deactivated membrane surface (fig 2) . Major changes will occur in the hexose transport protein, '5 ated with the proteins has occurred (fig 2) . If it is assumed that the number of protein copies remains the same the data suggest that either the two sulphydryl groups necessary for glucose binding are now missing or that they are unavailable owing to impaired protein mobility. In either event protein function is impaired. The difference in reactivity between normal and rheumatoid erythrocytes can be gauged by the kinetics of their response to glucose. Erythrocytes which had been depleted of glucose were incubated in a 5 mM glucose solution and the change in the thiol population with time was followed by Ellman's reagent. Figure 3 shows a typical response of depleted, deactivated erythrocytes from normal healthy volunteers on binding glucose and so exposing the hindered thiol groups on the exofacial surface. The t,, value reflects the rate of conformational change in the hexose transport protein during sugar binding and for erythrocytes from normal healthy volunteers this occurs at 0-86 (SEM 008) hours (fig 3) .
With erythrocytes from patients with rheumatoid arthritis the overall change is smaller and, in addition, the activity of those thiols capable of functioning is impaired. Here the t,2 occurs at 1-35 (0-2) hours. Statistical analysis by the MannWhitney U test indicated a significant (p<0 05) difference between the two groups. Thus both the sulphydryl group population on membrane and their reactivity to glucose are impaired in rheumatoid arthritis.
Conclusions
The erythrocyte is a cell which is often regarded as being too distant from the disease process to be of any major significance. In comparative studies between the diseased and the healthy state this passive cell is in many ways the cell of choice as a marker of in vitro activity, in that it has only a limited ability for repair and can effectively reflect such changes as membrane damage. In arthritis both the erythrocyte and plasma proteins circulate through areas close to the inflammatory sites.
They are also in contact with polymorphs, whose function is altered in the diseased state Two hypotheses can be constructed around these results. It is unlikely that the body produces a large variety of glucose transport proteins and it is a plausible assumption that the one present in the red cell will be the same, or only slightly modified in tertiary structure, as those implanted in the other important cells, such as the B and T lymphocytes, macrophages, and cells from the synovial lining. Thus any damage caused by the disease aetiology to the redox balance and nutritional status of the red cell would be expected to have a parallel in these cells. 
